Ellington Management Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-2,900
| Closed | -$690K | – | 424 |
|
|
2020
Q1 | $690K | Buy |
+2,900
| New | +$690K | 0.16% | 168 |
|
|
2018
Q4 | – | Sell |
-1,100
| Closed | -$212K | – | 598 |
|
|
2018
Q3 | $212K | Sell |
1,100
-1,400
| -56% | -$270K | 0.06% | 429 |
|
|
2018
Q2 | $425K | Sell |
2,500
-300
| -11% | -$51K | 0.03% | 194 |
|
|
2018
Q1 | $456K | Buy |
+2,800
| New | +$456K | 0.03% | 422 |
|
|
2017
Q4 | – | Sell |
-1,900
| Closed | -$289K | – | 823 |
|
|
2017
Q3 | $289K | Sell |
1,900
-4,000
| -68% | -$608K | 0.05% | 395 |
|
|
2017
Q2 | $760K | Buy |
5,900
+1,100
| +23% | +$142K | 0.11% | 134 |
|
|
2017
Q1 | $525K | Buy |
+4,800
| New | +$525K | 0.02% | 284 |
|
|
2015
Q3 | – | Sell |
-2,600
| Closed | -$321K | – | 916 |
|
|
2015
Q2 | $321K | Buy |
+2,600
| New | +$321K | 0.08% | 392 |
|
|
2014
Q2 | – | Sell |
-8,500
| Closed | -$601K | – | 672 |
|
|
2014
Q1 | $601K | Buy |
+8,500
| New | +$601K | 0.18% | 169 |
|